
Immunovant Inc (IMVT) Market Capitalization Overview
Market Cap: $2.68B as of Jun 13, 2025
$2.68B
Past Month+$312.19M (13.20%)
As of Jun 13, 2025, Immunovant Inc (IMVT) has a market capitalization of $2.68B. Over the past 30 days, its market cap has decreased by -2.48%, while in the last 12 months, it has decreased by -26.38%.
Market capitalization represents the total value of Immunovant Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Immunovant Inc (IMVT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Immunovant Inc (IMVT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Immunovant Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Immunovant Inc (IMVT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Immunovant Inc (IMVT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Immunovant Inc (IMVT) Market Cap & Key Trends
See Immunovant Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Immunovant Inc (IMVT)
Order type
Buy in
Order amount
Est. shares
0 shares
Immunovant Inc (IMVT) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $2.64B | -2.48% |
May 1, 2025 | $2.71B | +4.61% |
Apr 1, 2025 | $2.59B | -17.57% |
Mar 3, 2025 | $3.14B | -11.33% |
Feb 3, 2025 | $3.54B | -4.46% |
Jan 2, 2025 | $3.70B | -12.50% |
Immunovant Inc (IMVT) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $2.68B | -26.38% |
2024 | $3.64B | -40.34% |
2023 | $6.10B | +165.79% |
2022 | $2.30B | +134.03% |
2021 | $979.80M | -78.33% |
2020 | $4.53B | — |
FAQs About Immunovant Inc (IMVT) Market Cap
As of Jun 13, 2025, the market capitalization of Immunovant Inc (IMVT) is $2.68B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Immunovant Inc’s market capitalization has increased by 13.20%, changing from $2.37B to $2.68B as of Jun 13, 2025.
In the last 3 months, Immunovant Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Immunovant Inc’s market capitalization decreased from $6.10B in January to $3.64B in December, reflecting a -40.34% change.
In the past five years, Immunovant Inc (IMVT) has had a compound annual growth rate (CAGR) of -4.27% in market capitalization. This means its market cap has shrunk at an average rate of -4.27% per year.